Pseudobulbar affect

Pseudobulbar Affect
Synonyms	N/A
Pronounce	N/A
Specialty	N/A
Symptoms	Involuntary laughing or crying
Complications	Social embarrassment, depression
Onset
Duration
Types	N/A
Causes	Neurological disorders
Risks
Diagnosis	Clinical evaluation
Differential diagnosis	N/A
Prevention	N/A
Treatment	Medication, therapy
Medication	N/A
Prognosis	N/A
Frequency
Deaths	N/A

Pseudobulbar affect (PBA) is a neurological condition characterized by episodes of sudden, uncontrollable, and inappropriate laughing or crying. It is often associated with various neurological disorders and can significantly impact the quality of life of affected individuals.

Signs and Symptoms

Pseudobulbar affect is primarily marked by episodes of involuntary emotional expression, which are disproportionate or inappropriate to the social context. The key symptoms include:

• Sudden, uncontrollable episodes of laughter or crying.
• Emotional expression that is exaggerated or incongruent with the individual's actual emotional state.
• Episodes that may occur several times a day and last from seconds to minutes.

Causes

Pseudobulbar affect is typically associated with neurological conditions that affect the brain's ability to regulate emotions. Common causes include:

• Amyotrophic lateral sclerosis (ALS)
• Multiple sclerosis (MS)
• Stroke
• Traumatic brain injury (TBI)
• Alzheimer's disease and other forms of dementia
• Parkinson's disease

The exact pathophysiology of PBA is not fully understood, but it is believed to involve disruption of neural pathways that control emotional expression, particularly those involving the cerebellum, brainstem, and frontal lobes.

Diagnosis

Diagnosing pseudobulbar affect involves a thorough clinical evaluation. Key steps in the diagnostic process include:

• Detailed patient history to identify the frequency, duration, and triggers of emotional episodes.
• Neurological examination to assess for underlying neurological disorders.
• Use of standardized questionnaires, such as the Center for Neurologic Study-Lability Scale (CNS-LS), to quantify the severity of symptoms.

Treatment

Treatment of pseudobulbar affect focuses on managing symptoms and improving quality of life. Options include:

• Medication: The FDA-approved combination of dextromethorphan and quinidine (Nuedexta) is commonly used to reduce the frequency and severity of episodes. Other medications, such as antidepressants, may also be prescribed.
• Behavioral therapy: Cognitive-behavioral therapy (CBT) can help patients develop coping strategies to manage emotional episodes.
• Supportive care: Education and support for patients and caregivers to understand the condition and its impact.

Prognosis

The prognosis for individuals with pseudobulbar affect varies depending on the underlying neurological condition. While PBA itself is not life-threatening, it can lead to social embarrassment, isolation, and depression. Effective management of symptoms can improve social functioning and quality of life.

See Also

• Emotional lability
• Neurological disorder
• Mood disorder

External Links

• [Pseudobulbar Affect Foundation]
• [National Institute of Neurological Disorders and Stroke]

edit 

WikiMD neurology

External links

• Comprehensive information from the National Institute of health.
  

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z